Skip to playerSkip to main content
  • 5 years ago
Watch as Serum Institute of India's (SII) CEO Adar Poonawalla shares views on India's 100-crore Covid vaccine dose milestone, scaling up Covishield's production and the challenges he faced.
Comments

Recommended